Cinclus Pharma Holding AB (OSTO:CINPHA) Long-Term Capital Lease Obligation : kr0.16 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Long-Term Capital Lease Obligation?

Cinclus Pharma Holding AB's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.16 Mil.

Cinclus Pharma Holding AB's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (kr0.22 Mil) to Dec. 2024 (kr0.19 Mil) and declined from Dec. 2024 (kr0.19 Mil) to Mar. 2025 (kr0.16 Mil).

Cinclus Pharma Holding AB's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) but then increased from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr0.19 Mil).

Cinclus Pharma Holding AB Long-Term Capital Lease Obligation Historical Data

The historical data trend for Cinclus Pharma Holding AB's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Long-Term Capital Lease Obligation Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

0.61

0.19

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial						-	-	0.22	0.19	0.16

Cinclus Pharma Holding AB (OSTO:CINPHA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Cinclus Pharma Holding AB Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines